Related Experiment Video
Updated: May 14, 2026

A Standardized Procedure of Dressing Management for Toxic Epidermal Necrolysis
Published on: March 14, 2025
Severe DRESS syndrome managed with therapeutic plasma exchange
Thomas Alexander1, Edward Iglesia, Yara Park
1Department of Pediatrics, University of North Carolina at Chapel Hill, Chapel Hill, NC, USA. thomasbalexander@yahoo.com
Abstract:
Drug reaction with eosinophilia and systemic symptoms (DRESS) syndrome is a rare but increasingly described phenomenon of immune activation and organ dysfunction in association with a wide variety of medications. This reaction shows a broad spectrum of clinical presentation and severity, ranging from mild to lethal. Treatment strategies of immune suppression appear be helpful in some cases, but treatment failures occur frequently with reported mortality rates of 5% to 10%. We present a pediatric case of DRESS syndrome associated with either lamotrigine or bupropion, leading to multiorgan involvement and life-threatening complications of respiratory failure and cardiac arrest. After failing to improve with removal of these medications and administration of systemic corticosteroids, our patient showed dramatic, sustained clinical response to therapeutic plasma exchange. To our knowledge, this is the first reported case of therapeutic plasma exchange used for life-threatening DRESS syndrome in a pediatric patient. This case suggests needed research for this therapeutic option in life-threatening DRESS syndrome resistant to high-dose steroids.
Related Concept Videos
Nephrotic Syndrome III : Nursing Management
Pulmonary Embolism II: Diagnostic Studies and Interprofessional Care
Nephrotic Syndrome II : Assessment and Medical Management
Venous Thrombosis III: Interprofessional Care
Pleural Effusion II: Symptoms and Management
A pleural effusion is the abnormal collection of fluid between the parietal and visceral pleura layers of tissue that form the lining of the lungs and chest cavity. It can occur independently or due to surrounding parenchymal diseases, such as infection, malignancy, or inflammatory conditions.
Clinical Manifestations:
Nephrotic Syndrome I : Introduction
